Boston Scientific introduces new Kinetix Guidewire for use in PCI procedures

Boston Scientific Corporation (NYSE: BSX) today announced the launch of its new Kinetix™ Guidewire for use in percutaneous coronary intervention (PCI) procedures.  Guidewires are small flexible wires physicians use to deliver interventional devices such as drug-eluting stents.  The Kinetix Guidewire features a unique micro-cut nitinol sleeve designed for significantly improved torque control compared to conventional spring coil guidewires.  The Kinetix Guidewire represents the first major advance in coronary guidewire technology in nearly a decade. The Company will begin a phased launch of the Kinetix Guidewire immediately and expand to full product availability by next quarter.

Joseph DeGregorio, M.D., treated the first patient with the Kinetix Guidewire at Hackensack University Medical Center in Hackensack, New Jersey, marking the first procedure worldwide to employ this advanced coronary guidewire.

"The Kinetix Guidewire provided exceptional torque and flexibility," said Dr. DeGregorio.  "It's rare to find a workhorse guidewire that combines outstanding deliverability of the wire, support for device deliverability and an excellent safety profile.  The availability of Kinetix is welcome news for interventional cardiologists and their patients."

The Kinetix Guidewire builds on Boston Scientific's Synchro® Guidewires used in neurovascular interventions.  The micro-cut nitinol sleeve and a nitinol distal core are designed to provide increased torque transmission and flexibility while providing a soft distal tip that physicians often demand in a workhorse guidewire.  The responsiveness and maneuverability of the Kinetix Guidewire is designed to deliver excellent performance, safety and ease of use, benefiting both patient and physician.

"We're pleased to begin offering this innovative technology that should help physicians simplify coronary angioplasty procedures," said Hank Kucheman, Executive Vice President and President of Boston Scientific's Cardiology, Rhythm and Vascular Group.  "Kinetix reinforces our commitment to providing improved treatment options that promote better patient outcomes."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Online group programs aid weight loss but face hurdles